Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Corticosteroids: do they damage the cardiovascular system?

S R Maxwell1, R J Moots, M J Kendall

  • 1Department of Medicine, Queen Elizabeth Hospital, Edgbaston, Birmingham, UK.

Postgraduate Medical Journal
|December 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Type I interferon regulates cytokine-delayed neutrophil apoptosis, reactive oxygen species production and chemokine expression.

Clinical and experimental immunology·2020
Same author

APPA (apocynin and paeonol) modulates pathological aspects of human neutrophil function, without supressing antimicrobial ability, and inhibits TNFα expression and signalling.

Inflammopharmacology·2020
Same author

Janus kinase inhibitors prevent migration of rheumatoid arthritis neutrophils towards interleukin-8, but do not inhibit priming of the respiratory burst or reactive oxygen species production.

Clinical and experimental immunology·2017
Same author

Pharmacology and Therapeutics Education in the European Union Needs Harmonization and Modernization: A Cross-sectional Survey Among 185 Medical Schools in 27 Countries.

Clinical pharmacology and therapeutics·2017
Same author

Ghost busting--taking the sheet off the ghost.

Zeitschrift fur Rheumatologie·2016
Same author

Charles Dickens' favourite child and a new kind of ray.

Journal of clinical pharmacy and therapeutics·2016
Same journal

Dapagliflozin-induced anaphylactic shock.

Postgraduate medical journal·2026
Same journal

Comparative efficacy of Janus kinase inhibitors in severe alopecia areata: a network meta-analysis based on randomized controlled trials.

Postgraduate medical journal·2026
Same journal

Two cases of toxic epidermal necrolysis with severe ocular involvement treated with adjunctive tofacitinib.

Postgraduate medical journal·2026
Same journal

Diastolic dysfunction and diabetes: the DIADAD study-a retrospective cohort study from Liverpool.

Postgraduate medical journal·2026
Same journal

Care, cash, and proof: forensic accountability for war-related starvation.

Postgraduate medical journal·2026
Same journal

Response to traumatic injuries in polo players in England.

Postgraduate medical journal·2026
See all related articles

Corticosteroids effectively treat inflammatory diseases but increase the risk of premature atherosclerosis and cardiovascular mortality. Further research is needed to understand these adverse effects in steroid-treated patients.

Area of Science:

  • Cardiovascular Medicine
  • Rheumatology
  • Pharmacology

Background:

  • Corticosteroids are widely used for inflammatory conditions like rheumatoid arthritis and systemic lupus erythematosus.
  • While beneficial for mortality in some diseases, corticosteroid use is linked to adverse cardiovascular outcomes.
  • Increased vascular mortality is observed in rheumatoid arthritis, airway obstruction, and transplant recipients on corticosteroids.

Purpose of the Study:

  • To review clinical evidence of excess cardiovascular mortality in patients treated with corticosteroids.
  • To explore the underlying mechanisms contributing to steroid-induced cardiovascular damage.
  • To identify areas for future research into corticosteroid-related cardiovascular risks.

Main Methods:

  • Review of clinical evidence on corticosteroid effects on cardiovascular health.

Related Experiment Videos

  • Analysis of proposed mechanisms for corticosteroid-induced vascular damage.
  • Synthesis of data from various corticosteroid-treated patient populations.

    • Main Results:

    • Corticosteroid therapy is associated with a high incidence of premature atherosclerosis in diseases like systemic lupus erythematosus.
    • Elevated rates of vascular mortality are evident in rheumatoid arthritis, reversible airways obstruction, and transplant recipients.
    • Potential mechanisms include hypertension, impaired glucose tolerance, dyslipidemia, and altered thrombosis/fibrinolysis.

    Conclusions:

    • Corticosteroid use, despite its anti-inflammatory benefits, poses a significant risk of cardiovascular mortality.
    • Mechanisms such as metabolic disturbances and hemostatic imbalances contribute to this increased risk.
    • Further investigation is crucial to mitigate cardiovascular complications in patients undergoing corticosteroid treatment.